TrialESC heart failure2018

Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.

Hans-Dirk Düngen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.